Atom Grants
Discover
  • Dashboard
  • Search
  • Deep Research
  • Favorites
  • Projects

    Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)

    Forecasted

    This grant funds early-stage, highly innovative technology development projects to improve cancer research or clinical care, focusing on proof-of-concept studies with high potential impact in cancer-related fields.

    Browse similar grants
    Cancer Research Grants 2026
    OverviewSimilar Grants
    OverviewSimilar Grants

    Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)

    This grant funds projects to further develop and validate innovative technologies that advance cancer research or clinical care, focusing on technical improvements and rigorous validation for broad adoption.

    HHS-NIH11Forecasted Jun 4, 2027$300,000Forecasted

    Early-Stage Development of Informatics Technologies for Cancer Research and Management (U01 Clinical Trial Optional)

    NIH supports early-stage development of new or significantly adapted informatics tools for cancer research, from prototyping to initial dissemination, with user feedback and clear milestones.

    HHS-NIH11Due Jun 11, 2027$900,000

    Cancer Prevention and Control Clinical Trials Grant Program (R01 Clinical Trial Required)

    This grant supports investigator-initiated clinical trials to reduce cancer burden through early detection, prevention, and survivorship improvements.

    HHS-NIH11Due Jan 7, 2027

    Focused Technology Research and Development (R01 Clinical Trial Not Allowed)

    Supporting projects developing innovative technologies for biomedical research, advancing current capabilities for acquiring biomedical knowledge.

    HHS-NIH11Due Feb 5, 2027

    Academic-Industrial Partnerships for Translation of Technologies for Diagnosis and Treatment (R01 - Clinical Trial Not Allowed)

    Funding opportunity for academic-industrial partnerships to translate technologies for diagnosis and treatment in cancer research and care.

    HHS-NIH11Due Feb 5, 2027$2,495,000